key: cord-0756684-1yjhdi3b
authors: Ackermann, Maximilian; Mentzer, Steven J.; Kolb, Martin; Jonigk, Danny
title: Inflammation and Intussusceptive Angiogenesis in COVID-19: everything in and out of Flow
date: 2020-10-02
journal: Eur Respir J
DOI: 10.1183/13993003.03147-2020
sha: a9dc347dc81f27986fc23af0fff0429121d037ad
doc_id: 756684
cord_uid: 1yjhdi3b

Inflammation and Intussusceptive Angiogenesis in COVID-19

The human body contains 60,000 miles of blood vessels, including at least 19 billion capillaries, so that under physiological conditions cells are located no further than 100-200μm from the nearest capillary. In those, endothelial cells and pericytes seem to play a pivotal role in COVID-19 by binding SARS-CoV-2 to the angiotensin-convertingenzyme 2 (ACE-2) (1, 2) . In the lung, the transmembrane ACE-2 receptor is predominantly expressed in endothelial cells, perivascular pericytes, and type 2 cells (2, 3) .

We recently showed that SARS-CoV-2-infection leads to angiocentric inflammation in COVID-19-induced respiratory failure with a greater number of ACE2positive endothelial cells compared to uninfected controls or to post mortem lung tissue from patients succumbed to influenza A related ARDS (1) . Although the SARS-CoV-2 detection of SARS-CoV-2 in post mortem tissue by transmission electron microscopy is a challenging task (4), replicated virus-like particles were observed enveloped in endothelial cells (1, 5) , lymphatic cells (6) , but also in type 2 and 1 pneumocytes (6,7).

Increasing clinical evidence shows that endothelial dysfunction is a common denominator after SARS-COV-2 infection in the multi-organ complexity and severity of COVID-19 (3). COVID-19 related endothelial dysfunction is characterized by acute vascular inflammation and perivascular T-cell recruitment leading to disruption of alveolar-capillary barrier and increased permeability (1) (2) (3) . The endothelial cells surrounded by T-lymphocytes show features of strong activation referred to as "endothelialitis", a process typically seen during rejection of solid organ transplants.

The infection of endothelial cells by SARS-CoV-2 results in swelling and disruption of the endothelial cell barriers, an anomalous microvascular architecture, and an endothelial dysfunction (1, 3) . These vascular injuries are accompanied by thrombosis, vasoconstriction and distinct intussusceptive angiogenesis, a unique rapid process of blood vessel neoformation by splitting a vessel in two lumens by an incorporation of circulating angiogenic cells (1,3). (Fig. 1A) . In the pulmonary circulation of COVID-19 autopsies, we observed a distinct occurrence of intussusceptive angiogenesis not only in early SARS-CoV-2 infected lungs, but also in lung tissue with an infection lasting more than 20 days. Beyond these findings in COVID-19 post mortem lung tissue, we revealed distinctive features of compensatory angiogenesis by intussusception in many other organs as heart, liver, kidney, brain and lymphoreticular organs in patients succumbed to COVID-19. The chaotic vessel regulation of focally vasoconstricted and progressively dilated vessel segments results in severe disturbances of physiological laminar flow. Two major forms of thrombi have been reported so far in COVID-19 patients (8) . Pulmonary embolism in larger pulmonary vessels probably based on DVT were seen in a minority of COVID-19 patients whereas the vast majority demonstrated platelet aggregates obstructing the microvasculature and the peripheral vascularity by fibrin strands, activated platelets, deformed neutrophils, and neutrophil extracellular traps (8, 9) . Viral-associated thrombotic microangiopathies have been described in numerous inflammatory cardiorespiratory diseases (e.g. influenza (10) or myocarditis (11) ). We compared post-mortem lung tissues from patients who died from COVID-19

with severe ARDS and diffuse alveolar damage due to influenza A (H1N1) infection.

Thereby, we realized nine times more microthrombi in COVID19-lungs compared to influenza A (H1N1)-lungs (1). The microangiopathy observed in COVID-19 patients-specifically, the vasoconstriction and clotting in smaller blood vesselsresults in hypoxia, shunting and an increase of pulmonary vascular resistance (8) .

Interestingly, COVID-19 does not show characteristics of a "typical" ARDS (12) . The discrecancy between a general well-preserved lung mechanics and the severity of vessel morphology determine the shear stress on the vascular wall (13) . In general, high shear stress, as observed in physiological laminar flow, is considered, angioprotective promoting endothelial cell survival, vasodilation, and anticoagulation (14, 15) . Low shear stress, on the other hand, results in the secretion of vasoconstrictors, platelet aggregation, coagulation, and pathological reshaping of microvascular architecture (15) (16) (17) . The pathologic consequences of these blood flow dynamics have been described in many diseases such as atherosclerosis (18), inflammatory diseases (15, 17) , and malignancies (16) . Our own hemodynamic studies on inflammatory-related changes of the blood flow (13, 14, 17) Activated T-cells attracted by chemotactic chemokines (e.g. CCL17, CCL8, or CCR1) (1) preferentially adhere to activated endothelial cells (19, 20) . Despite an increase in inflammatory blood flow and increased wall shear stress, transendothelial lymphocyte recruitment can occur in selected capillary beds (liver and lung), post-capillary venules (most parenchymal organs), and even specialized vascular segments that acquire structural modifications that reduce flow velocity and wall shear stress (21) . Therefore, the structure of the microcirculation is continuously adapting to metabolic demands and immunosurveillance. The close association of inflammation and angiogenesis represents a pivotal pillar in perpetuating inflammatory processes during wound healing and infections such as COVID-19. Inflamed human endothelial cells and pericytes express high levels of toll-like receptors (TLRs) which are recognized together with their intracellular adaptor protein MyD88 as sentinels of the innate immune system (22) .

Stimulation of endothelial TLRs and MyD88 results in a release of cytokines (e.g. IFNγ, TNFα, Il1α, G-CSF), chemokines, leucocyte adhesion molecules (e.g. E-selectin, ICAM1, VCAM1), procoagulation mediators (e.g. fibrin, PAI, vWF), and proangiogenic factors (e.g. VEGF, NOS, or CD14 monocytes) (25) .

"Intussusceptive" (non-sprouting) angiogenesis is a well-characterized morphogenetic process in cancer (26) , inflammatory diseases and tissue regeneration (27) . Distinct from intussusceptive angiogenesis, sprouting angiogenesis is characterized by sprouts composed of endothelial cells. The endothelial sprouts typically grow toward an angiogenic stimulus (such as VEGF-A) and add vessels to tissues devoid of blood vessels. Intussusceptive angiogenesis is a rapid process of intravascular septation that produces two lumens from a single vessel within minutes. The process appears to recruit bone-marrow derived mononuclear cells-expanding and adapting capillary plexuses without requiring active proliferation of endothelial cells ( Figure 1B) (28) . The newly formed "intussusceptive pillars" (Fig. 1C) are then permeated by pericytes and myofibroblasts providing mechanical stabilization of the transcapillary pillar core. We previously showed that this formation of intussusceptive pillars is primarily located in dilated vascular segments with low blood flow velocity and reduced wall shear stress (12, 13) . Recently, CXCL12/CXCR4 signaling has been identified as an important molecular regulator of intussusceptive angiogenesis and hypoxia (29) : the positive feedback loop between vascular shear stress, CXCL12 (SDF1)-expression, hypoxia and the release of eNOS has been identified as an adaptation of the vascular system to maintain blood flow responsive to the demands of prolonged inflammation. Therefore, the pronounced release of eNOS cascade is a pivotal physiological process to maintain blood flow into tissues with occluded vessels and to initiate tissue repair by expanding the vascular architecture by intussusceptive angiogenesis. In our own studies, we observed abundant intussusceptive angiogenesis in the disrupted pulmonary vascular architecture of patients who died of COVID-19 (Fig. 1C, D) , stated in numbers nearly three times higher than in influenza A (H1N1)-lungs. Furthermore, the expression of CXCL12 and CXCR4 was highly upregulated in these COVID-19 lungs and was associated with dense T-cell infiltration.

These findings are consistent with inflammation-induced angiogenesis observed in other conditions such as colitis (30, 31) and malignant tumors (26) .

In a recent morphomolecular study published in the European Respiratory Journal (32), we demonstrated the presence and impact of microvascular alterations in fibrotic interstitial lung diseases. We observed a higher frequency of intussusceptive features in the injury patterns of NSIP and AFE fibrotic lungs whereas UIP lungs revealed compensatory angiogenesis predominantly by sprout formation (32, 33) . In addition, intussusceptive angiogenesis was observed in chronic pulmonary vascular diseases with variable degree of thrombosis, such as CTEPH (34), pulmonary capillary hemangiomatosis (35, 36) , and pulmonary veno-occlusive disease (PVOD) (35) ( Table   1 ). Although the pathologic mechanisms underlying fibrotic remodeling in pulmonary thromboembolic occlusions are poorly understood, thrombofibrosis and endothelialmesenchymal transition seem to be promoted by hypoxia-induced activation of endothelial cells, intussusceptive angiogenesis, activation of mesenchymal cells and immune cells (31) (32) (33) (34) . There is a compelling evidence that at least the progress and severity of progressive interstitial lung disease may be influenced by coagulation and fibrinolytic capacities and vascular permeability (38, 39) , although the therapeutic use of orally-administered anticoagulants has been critically evaluated in IPF patients (40) . 

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

Electron microscopy of SARS-CoV-2: a challenging task

Pulmonary Vascular Pathology in Covid-19. Reply

Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States

Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series

Thrombosis and COVID-19 pneumonia: the clot thickens!

Vascular occlusion by neutrophil extracellular traps in COVID-19

Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which Contributes to Lung Injury

Parvovirus B19-induced angiogenesis in fulminant myocarditis

COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome

Blood flow shapes intravascular pillar geometry in the chick chorioallantoic membrane

Computational flow dynamics in a geometric model of intussusceptive angiogenesis. Microvascular Research

Structural adaptations in the murine colon microcirculation associated with hapten-induced inflammation

Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Research

Blood flow patterns spatially associated with platelet aggregates in murine colitis

Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases

T-cell function and migration. Two sides of the same coin

LFA-1 and L-selectin regulation of recirculating lymphocyte tethering and rolling on lung microvascular endothelium

Microangiectasias: structural regulators of lymphocyte transmigration

Endothelial-to-mesenchymal transition in pulmonary hypertension

Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs

Myd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis

Vascular endothelial cell Toll-like receptor pathways in sepsis

Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing's sarcoma A673-xenograft growth and normalize tumor vascular architecture

Sprouting and intussusceptive angiogenesis in postpneumonectomy lung growth: mechanisms of alveolar neovascularization

Intussusceptive angiogenesis: expansion and remodeling of microvascular networks

SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception

Inflammation-induced intussusceptive angiogenesis in murine colitis

Intussusceptive remodeling of vascular branch angles in chemically-induced murine colitis

Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases

Demystifying morphomolecular alterations of vasculature in interstitial lung diseases

Plexiform Vasculopathy in Chronic Thromboembolic Pulmonary Hypertension. Am J Respir Crit Care Med

Comprehensive three-dimensional morphology of neoangiogenesis in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis

Pulmonary capillary haemangiomatosis: a distinct entity?

From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension

The pathogenesis of pulmonary fibrosis: a moving target

Vascular permeability in the fibrotic lung

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis